Back to mobile site

Piper Sandler Reiterates Overweight Rating on Tenaya Therapeutics Inc (TNYA)

October 18, 2024 7:50 AM EDT Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $40.00 price target on Tenaya Therapeutics Inc (NASDAQ: TNYA).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login